Sevoflurane in Electroconvulsive Therapy

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Inonu University
• Treatments: Sevoflurane

Criteria

Inclusion Criteria:

• Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia

Exclusion Criteria:

• Pregnancy

• Cerebrovascular disease

• Epilepsy

• Unstable cardiovascular disease

• Chronic obstructive pulmonary disease; and

• Renal or hepatic failure